GLYPICAN 3

Glypican-3 is a cell surface protein that is overexpressed in hepatocellular carcinoma (HCC). This test aids in diagnosing liver cancer and distinguishing it from benign liver conditions.

Also known asIhc - Glypican-3 Ihc - Glypican-3

Available via

Home Collection, Lab Visit

Contains

3 parameters

Earliest reports in

3 Working Days

Test details

GLYPICAN 3 Test in Vadodara Overview

Preparations

No special preparations needed

Test included
GLYPICAN 3 includes 3 parameters

  • Request Letter
  • Additional Communication
  • Glypican 3
Frequently Asked Questions

The Glypican Serum test is a diagnostic blood test used to measure the levels of glypicans, a family of heparan sulfate proteoglycans that play a critical role in cell growth, differentiation, and signaling pathways. Glypicans are particularly important in developmental biology and have been linked to certain cancers, including hepatocellular carcinoma. This test is often used in research and clinical settings to assess tumor markers and developmental disorders.

Doctors may recommend this test to evaluate glypican expression in cases of suspected liver cancer, neurological disorders, or congenital abnormalities. Since glypicans are involved in cell signaling and tumor growth, abnormal levels could indicate the presence of malignancies or developmental defects. This test can also be used as part of a broader cancer screening panel or in monitoring disease progression.

A blood sample is drawn from a vein in the patient’s arm and analyzed using laboratory techniques to measure glypican levels. The test requires no special preparation, although patients should inform their doctors about any medications they are taking, as certain drugs might interfere with results. The processing time for results varies but is typically available within a few days.

Elevated glypican levels can be associated with hepatocellular carcinoma, certain neurological disorders, and developmental abnormalities. In contrast, low levels may not necessarily indicate a disease but could be of interest in research settings. Since glypicans are involved in cancer biology, an abnormal result usually necessitates further testing to determine the exact cause.

If the test shows abnormal glypican levels, the doctor may recommend additional diagnostic procedures such as imaging studies, biopsies, or genetic testing to confirm a diagnosis. Treatment options will depend on the underlying condition, ranging from cancer therapies to targeted treatments for developmental disorders. Follow-up testing may also be required to monitor changes in glypican levels over time.

Test code

Z274K

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Paraffin BlockOthers2 NOS
TissueOthers2 NOS

Specimen stability information

Paraffin Block, Tissue

Collection instructions

Site Of Biopsy Specimen + Clinical Details. Relevant Radiology Findings: X-Ray/Ct/Mri Report Images (Soft Copy). If tissue received, tissue processing will be charged.

Specimen rejection criteria

Test run frequency

Every Day TIME - 08:00

Turn around time

3 Working Days

Performing locations

Department

  • Histopath

CPT and Loinc codes

GLYPICAN 3

2700